An investigation on behalf of current long term investors in shares of Dex One Corporation (NYSE: DEXO) concerning possible breaches of fiduciary duties related to potential excessive compensation that was awarded to certain senior officers and executives at Dex One Corp. was announced.

The investigation by a law firm focuses on whether the directors and officers of Dex One Corporation harmed the company by breaching their fiduciary duties to shareholders. In particular the investigation on behalf of current long term investors in Dex One Corp. (NYSE: DEXO) focuses on possible shareholder claims that certain of Dex Ones senior officers and executive were unjustly enriched through their receipt of unwarranted, excessive or unearned compensation in past years.

Dex Ones CEO earned a total of $5.165million in 2010. Its CFOs pay rose from roughly $920,000 in 09 to $3.661million in 2010, its EVP Sales & Marketing compensation increased from $847,000 in 2009 to $2.865million in 2010, and its SVP and General Counsels pay rose from about $635,000 in 2009 to $1.578million in 2010.

However, Dex Ones shareholders recently expressed their disdain for executive pay packages by voting no on Dex One's say on pay provision. Dex One Corporation received only 48 % support for its pay practices at its May 3 annual meeting, according to a company filing.

The investigation concerns possible claims that the prior compensation awarded at Dex One Corporation is improper based upon its current operating condition.

Dex Ones 12months Revenue fell from $2.68billion in 2007 to $991million in 2010. Even though Dex One Corporation reported a Net Income of $5.996billion in 2010 it reported in 2009 a substantial Net Loss of $6.43billion, respectively in 2008 a Net Loss of $2.29billion.

Shares of Dex One Corporation (Public, NYSE:DEXO) fell from over $30 in April 2010 to under $2 recently.

The investigation seeks to determine whether certain senior officers and executives at Dex One Corp. were awarded salaries, bonuses, stock options and other forms of long-term, incentive or retirement compensation that were excessive or unwarranted based on the Dex Ones performance as compared to what senior officers and executives at comparable companies were making and/or results that were fraudulent, misleading or not long-lasting.

Finally the investigation focuses also on possible shareholder claims that would allow Dex One (NYSE: DEXO) stockholders to more efficiently influence or control future compensation decisions at Dex One Corporation.